Medtronic plc (MDT) — Stock Price, Chart & Analysis
Medtronic plc (MDT) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $116.11B and a trailing P/E ratio of 22.36. Over the past 52 weeks, MDT has traded between $73.31 and $106.33. Medtronic plc pays a dividend yielding 3.1%. View the live MDT chart, technical opinion, analyst ratings, fundamentals and latest news below.
Medtronic plc (MDT) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $116.11B |
| P/E ratio (TTM) | 22.36 |
| EPS (TTM) | $4.06 |
| Dividend yield | 3.1% |
| 52-week high | $106.33 |
| 52-week low | $73.31 |
| Beta | 0.57 |
| Avg. volume | 7.97M |
| Sector | Healthcare |
| Industry | Medical Devices |
Frequently asked questions about Medtronic plc (MDT)
How much does one share of Medtronic plc cost?
As of the latest update, one share of Medtronic plc (MDT) trades at $100 (+0.00% today).
What is Medtronic plc's market cap?
Medtronic plc has a market capitalization of approximately $116.11B.
What is Medtronic plc's P/E ratio?
Medtronic plc has a trailing price-to-earnings (P/E) ratio of 22.36.
What is Medtronic plc's earnings per share (EPS)?
Medtronic plc's trailing twelve-month EPS is $4.06.
Does Medtronic plc pay a dividend?
Yes — Medtronic plc pays a dividend with a yield of 3.1% ($2.88 per share annually).
What is Medtronic plc's 52-week trading range?
Over the past year, MDT has traded between $73.31 and $106.33.
What is the analyst price target for Medtronic plc?
The mean analyst price target for Medtronic plc is $104.83. This is informational only and not investment advice.
Latest Medtronic plc (MDT) news
- Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet NowNews · Sep 23, 2026
- Jim Cramer Called Medtronic a "Quandary." Here's Why He's Exactly Right.News · Sep 22, 2026
- Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key PlayersNews · Sep 21, 2026
- What Does Medtronic (MDT) FDA Clearance Mean For Its Hugo Surgery Push?News · Sep 19, 2026
- Vascular Access Device Market by Type, Route of Insertion, Application, End User - Global Forecast to 2031News · Sep 18, 2026
- Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?News · Sep 17, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live MDT dashboard…